A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation.

Peng Yeh Chih-Ming Chang Li-Jen Liao Ping-Chia Cheng Chen-Hsi Hsieh Pei-Wei Shueng Po-Wen Cheng Wu-Chia Lo

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)

The pretreatment Hb, pretreatment SII, posttreatment SII, and posttreatment SIRI are associated with survival in patients with stage IV oropharyngeal cancers. The developed nomogram aids in survival prediction and treatment adjustment.

Keyphrases

squamous cell carcinoma
free survival
lymph node metastasis
locally advanced
rectal cancer
antiretroviral therapy
replacement therapy
childhood cancer